Anti Factor Xa activity, LMW heparin (Citrated plasma, frozen (cp))

Testcode:	E_AFLMW
Specimens:	1 ml Citrated plasma, frozen (cp)
Preanalytics/Notes:	Please always send a separate specimen for this test. To avoid clotting please mix test tube carefully several times directly after collection of blood. Please centrifuge sample at least for 15 minutes (1500 x g). Plasma / supernatant should be transferred by pipette to a collection tube without any buffer or other substances. Please label as citrated plasma. Freeze and send frozen. No blood sampling from central venous catheter.
Method:	Chromogenic assay
Dimension:	IU/ml
Set-up:	Mon Tue Wed Thu Fri Sat Sun
Duration:	2 days
Indication/Significance:	Monitoring of treatment with low-molecular-weight or synthetic heparins, heparinoids
Interpretation:	The above-mentioned more… The above-mentioned target values should be aimed at in order to achieve the desired heparinisation success. close

both sex

Therapeutic range 4 h after application of LMWH: Thromboprophylaxis: 0.2 - 0.4 IU/ml Therapeutic administration: - Enoxaparin and Nadroparin twice daily: 0.6 - 1.0 IU/ml Application once daily - Enoxaparin: > 1.0 IU/ml - Tinzaparin: 0.85 IU/ml - Nadroparin: 1.3 IU/ml - Dalteparin: 1.05 IU/ml (American College of Chest Physicians 2012)